Human Parechovirus: an Emerging Cause of Sepsis-Like Syndrome in Infants Aged under 3 Months
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to investigate the clinical characteristics of human parechovirus (HPeV) infection in sepsis-like syndrome in infants aged under 3 months. Methods: Medical records of infants aged under 3 months with sepsis-like symptoms who were admitted between July 1, 2018 and August 31, 2018 were reviewed. A multiplex reverse transcription-polymerase chain reaction panel test was performed on the cerebrospinal fluid (CSF). Thirty-nine enrolled infants were categorized into three groups: 11 in group 1 (HPeV detected in the CSF), 13 in group 2 (enterovirus detected in the CSF), and 15 in group 3 (no virus detected in the CSF). Results: Compared with groups 2 and 3, a higher proportion of group 1 had tachycardia, tachypnea, apnea, and hypotension (P<0.05). A significantly lower white blood cell (WBC) count was noted in group 1 than in groups 2 and 3 (5,622±2,355/μL, 9,397±2,282/μL, and 12,312±7,452/μL, respectively; P=0.005). The CSF WBC count was lower in group 1 than in groups 2 and 3 (0.9±1.7/μL, 85.1±163.6/μL, and 3.7±6.9/μL, respectively; P=0.068). The proportion of patients requiring inotrope support (36.6% vs. 0% and 6.6%), mechanical ventilation (18.1% vs. 0% and 0%), and high flow nasal cannula (45.4% vs. 15.3% and 6.6%) was higher in group 1 than in groups 2 and 3. All patients recovered completely without complications. Conclusions: HPeV infection shows a severe clinical course and can cause a severe sepsis-like syndrome in infants aged under 3 months. Early diagnosis and proper treatment of HPeV infection are required.
Abstract
Purpose: This study aimed to investigate the clinical characteristics of human parechovirus (HPeV) infection in sepsis-like syndrome in infants aged under 3 months. Methods: Medical records of infants aged under 3 months with sepsis-like symptoms who were admitted between July 1, 2018 and August 31, 2018 were reviewed. A multiplex reverse transcription-polymerase chain reaction panel test was performed on the cerebrospinal fluid (CSF). Thirty-nine enrolled infants were categorized into three groups: 11 in group 1 (HPeV detected in the CSF), 13 in group 2 (enterovirus detected in the CSF), and 15 in group 3 (no virus detected in the CSF). Results: Compared with groups 2 and 3, a higher proportion of group 1 had tachycardia, tachypnea, apnea, and hypotension (P<0.05). A significantly lower white blood cell (WBC) count was noted in group 1 than in groups 2 and 3 (5,622±2,355/μL, 9,397±2,282/μL, and 12,312±7,452/μL, respectively; P=0.005). The CSF WBC count was lower in group 1 than in groups 2 and 3 (0.9±1.7/μL, 85.1±163.6/μL, and 3.7±6.9/μL, respectively; P=0.068). The proportion of patients requiring inotrope support (36.6% vs. 0% and 6.6%), mechanical ventilation (18.1% vs. 0% and 0%), and high flow nasal cannula (45.4% vs. 15.3% and 6.6%) was higher in group 1 than in groups 2 and 3. All patients recovered completely without complications. Conclusions: HPeV infection shows a severe clinical course and can cause a severe sepsis-like syndrome in infants aged under 3 months. Early diagnosis and proper treatment of HPeV infection are required.
참고문헌 (24)
- Olijve L, "Human parechovirus : an increasingly recognized cause of sepsis-like illness in young infants", Clin Microbiol Rev, 31, pp.e00047-17~ (2017)
- Aizawa Y, "Human parechovirus type 3 infection : an emerging infection in neonates and young infants", J Infect Chemother, 23, pp.419~426 (2017)
- Khatami A, "Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia", Clin Infect Dis, 60, pp.228~236 (2015)
- Cumming G, "Parechovirus genotype 3 outbreak among infants, New South Wales, Australia, 2013–2014", Emerg Infect Dis, 21, pp.1144~1152 (2015)
- Han TH, "Human parechovirus-3 infection in children, South Korea", J Clin Virol, 58, pp.194~199 (2013)
- 서지현, "Prevalence of human parechovirus and enterovirus in cerebrospinal fluid samples in children in Jinju, Korea", Clinical and Experimental Pediatrics, 58(3), pp.102~107 (2015), 대한소아청소년과학회
- Fleming S, "Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age : a systematic review of observational studies", Lancet, 377, pp.1011~1018 (2011)
- Task Force on Blood Pressure Control in Children, "Report of the second task force on blood pressure control in children--1987", Pediatrics, 79, pp.1~25 (1987)
- Task Force on Prolonged Infantile Apnea, "Prolonged infantile apnea : 1985", Pediatrics, 76, pp.129~131 (1985)
- Byington CL, "Normative cerebrospinal fluid profiles in febrile infants", J Pediatr, 158, pp.130~134 (2011)
- Harvala H, "Human parechoviruses : biology, epidemiology and clinical significance", J Clin Virol, 45, pp.1~9 (2009)
- Britton PN, "Parechovirus : an important emerging infection in young infants", Med J Aust, 208, pp.365~369 (2018)
- Renaud C, "Human parechovirus 3 : the most common viral cause of meningoencephalitis in young infants", Infect Dis Clin North Am, 29, pp.415~428 (2015)
- Jeziorski E, "Relevance of human parechovirus detection in cerebrospinal fluid samples from young infants with sepsis-like illness", J Clin Lab Anal, 29, pp.112~115 (2015)
- Sharp J, "Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations", Pediatr Infect Dis J, 32, pp.213~216 (2013)
- Ferreras Antolín L, "Increased detection of human parechovirus infection in infants in England during 2016 : epidemiology and clinical characteristics", Arch Dis Child, 103, pp.1061~1066 (2018)
- Loi C, "An erythematous palmoplantar rash due to human parechovirus", Arch Dis Child, 101, pp.1070~ (2016)
- Shoji K, "Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants", Pediatr Infect Dis J, 32, pp.233~236 (2013)
- Schuffenecker I, "Human parechovirus infections, Lyon, France, 2008–10 : evidence for severe cases", J Clin Virol, 54, pp.337~341 (2012)
- Harvala H, "Distinct systemic and central nervous system disease patterns in enterovirus and parechovirus infected children", J Infect, 69, pp.69~74 (2014)
- Verboon-Maciolek MA, "Severe neonatal parechovirus infection and similarity with enterovirus infection", Pediatr Infect Dis J, 27, pp.241~245 (2008)
- Britton PN, "Parechovirus encephalitis and neurodevelopmental outcomes", Pediatrics, 137, pp.e20152848~ (2016)
- Shakeel S, "Multiple capsid-stabilizing interactions revealed in a high-resolution structure of an emerging picornavirus causing neonatal sepsis", Nat Commun, 7, pp.11387~ (2016)
- Wildenbeest JG, "Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant", Pediatrics, 132, pp.e243~e247 (2013)